To ascertain if HAX1 protein levels in primary tumor can be used as a prognostic factor in breast cancer, we analyzed follow-up patient data and recorded time to distant recurrence and/or time to death from any cause for all 46 patients. This evidence concerns the gene HAX1 and neoplasm.